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Abstract
Background: During the initial COVID-19 outbreak up to 28.4 million elective operations were cancelled worldwide, in part owing to
concerns that it would be unsustainable to maintain elective surgery capacity because of COVID-19-related surgeon absence.
Although many hospitals are now recovering, surgical teams need strategies to prepare for future outbreaks. This study aimed to
develop a framework to predict elective surgery capacity during future COVID-19 outbreaks.
Methods: An international cross-sectional study determined real-world COVID-19-related absence rates among surgeons. COVID-19-
related absences included sickness, self-isolation, shielding, and caring for family. To estimate elective surgical capacity during
future outbreaks, an expert elicitation study was undertaken with senior surgeons to determine the minimum surgical staff required
to provide surgical services while maintaining a range of elective surgery volumes (0, 25, 50 or 75 per cent).
Results: Based on data from 364 hospitals across 65 countries, the COVID-19-related absence rate during the initial 6 weeks of
the outbreak ranged from 20.5 to 24.7 per cent (mean average fortnightly). In weeks 7–12, this decreased to 9.2–13.8 per cent. At all
times during the COVID-19 outbreak there was predicted to be sufficient surgical staff available to maintain at least 75 per cent of reg-
ular elective surgical volume. Overall, there was predicted capacity for surgeon redeployment to support the wider hospital response
to COVID-19.
Conclusion: This framework will inform elective surgical service planning during future COVID-19 outbreaks. In most settings,
surgeon absence is unlikely to be the factor limiting elective surgery capacity.
Introduction
The COVID-19 pandemic has had a significant impact on elec-
tive surgical care. A global scale projection estimated that 28.4
million elective operations will be cancelled during initial
COVID-19 outbreaks1. Perioperative COVID-19 is associated
with significantly increased morbidity and mortality2,3, so rou-
tine operations have been postponed, avoiding patients being
exposed to the risk of in-hospital SARS-CoV-2 infection4–6.
Hospitals have also cancelled elective operations to release
critical care capacity for patients with COVID-19, and surgeons
have been redeployed to support the hospital response in other
areas, including critical care, acute medicine, and emergency
departments6,7.
Surgeons may be at increased risk of SARS-CoV-2 exposure
and illness because of aerosolization in surgical smoke and con-
taminated tissues5,8–14. In addition to COVID-19 sickness, some
surgeons may need to self-isolate, shield, or take care of family
members, further depleting staffing of surgical services15,16.
Orthopaedic teams from China have reported sickness rates of
up to 20 per cent. A large-scale multispecialty international
assessment of surgeon sickness rates during the SARS-CoV-2
pandemic has not been undertaken previously.
Many hospitals are now recovering from the initial impact of
COVID-19, but future outbreaks are likely to happen17. To avoid
growing backlogs of postponed operations, surgical services
must plan to provide sufficient staff to be able to maintain
elective surgery during upcoming outbreaks. This study aimed
to determine the COVID-19-related absence rate among
surgeons, and to develop a framework for predicting workforce
capacity needed for elective surgery capacity during future
COVID-19 outbreaks.
Methods
The methodology is summarized in Fig. 1. First, an international,
multispecialty, cross-sectional study was completed to deter-
mine COVID-19-related absence rates. Second, an expert elicita-
tion study was undertaken with senior surgeons to determine the
minimum staff required to provide surgical services across a
range of scenarios. This informed the development of a frame-
work to predict the number of staff needed to support elective
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surgery capacity during future outbreaks in a range of scenarios.
Data were collected using REDCap, a secure, web-based elec-
tronic data capture tool, hosted at the University of Birmingham
(Birmingham, UK).
Cross-sectional study of COVID-19-related
absence rates
Surgeons were invited to participate in a cross-sectional study of
COVID-19-related absences through the international, multispe-
cialty COVIDSurg research network’s e-mail list and social media
platforms (Twitter: @CovidSurg; Instagram: @CovidSurg). The
surgeons were invited to participate in an online survey that was
open from 25 March 2020 to 15 April 2020. Surgeons across all
surgical specialties in any country affected by a COVID-19 out-
break were eligible to participate. Surgeons were defined as medi-
cal doctors with any level of training whose main clinical activity
was within a surgical department. This included junior doctors in
training, non-training grade doctors, and senior surgeons (con-
sultant or attending surgeons).
Participants were asked to report the COVID-19-related ab-
sence rate for their current surgical team at the time of survey
completion. COVID-19-related absence was defined as inability to
attend work activities owing to: sickness (COVID-19 symptoms
with or without a confirmatory swab test); or other COVID-19 re-
lated absence, including self-isolation after recent contact with a
person known to have COVID-19, shielding owing to pregnancy or
a pre-existing medical condition, or care of sick or dependent
family members. The participants were asked to report surgeon
sickness rates and other COVID-19-related absence rates, as de-
fined above. Total surgeon absence rate within teams was
obtained by summing the two figures.
Participants were also asked to classify their hospital as: cur-
rently treating patients with suspected COVID-19; previously (but
not currently) having treated patients with COVID-19; or never
having treated patients with COVID-19. Hospitals that were
currently treating patients with suspected COVID-19 were further
classified by CRITCON level18. CRITCON assesses hospital capacity,
strain the hospital is under, and resource availability; an increase
in CRITCON level indicates escalating systemic stress in the hospi-
tal (level 0, business as usual; level 1, normal winter; level 2, un-
precedented; level 3, full stretch; level 4, emergency) (Table S1).
Responses from different surgical specialty teams within a par-
ticular hospital were treated as independent data inputs (indepen-
dent responses), as they represented separate team structures,
often with different sized teams. If the same surgical team sub-
mitted multiple responses within a 14-day period, the reported ab-
sence rates were averaged and the response date was considered
to be the midpoint between response dates. If there were multiple
responses submitted from the same team more than 14 days
apart, these were treated as separate data inputs to allow any
changes in COVID-19-related absence rates to be captured as the
outbreak progressed. A detailed flow chart describing this meth-
odology can be found in Fig. S1. Invalid and incomplete responses
were excluded at the beginning of the analysis. A response was
considered incomplete if there were no data on absence rates,
country or date of response (as these data were needed to define
the time since local emergence of the outbreak). A response was
excluded as invalid if the reported absence rates exceeded 100 per
cent, as this would indicate an error in data entry.
The interval from the first COVID-19 case in the local commu-
nity until the time of the participants’ response was determined.
To calculate this, the date of local COVID-19 emergence was
recorded at the lowest possible administrative level (city, region,
country) (Table S2). Responses were stratified into 2-weekly inter-
vals from the time of local COVID-19 emergence.
Expert elicitation of minimum staffing
requirements
Surgeons were selected from across the international COVIDSurg
network to participate in an expert elicitation exercise on the
COVID-19-related absence rate Minimum staffing requirements
Expert elicitation exercise to determine minimum
numbers of surgeons needed to maintain surgical
services across different sizes of surgical service, while
maintaining various levels of regular elective surgical
volume during COVID-19 outbreak
Cross-sectional survey to determine COVID-19-related
absence rates for surgeons, stratified by time since
local emergence of COVID-19
Estimates of COVID-19 absence rates benchmarked against minimum staffing requirements, to develop a framework for predicting
elective surgery capacity throughout COVID-19 outbreaks
Framework stratified by
Surgical service size
Small, medium large team
Level of regular elective surgical
volume continued during COVID-19
outbreak
75, 50, 25, 0%
TIme since local COVID-19 emergence
< 2, 2–4, 4–6, 6–8, 8–10, 10–12 weeks
Fig. 1 Methodology used to build prediction framework
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basis of their experience of managing surgical services. A struc-
tured elicitation exercise was undertaken, with the experts asked
to estimate the minimum number of surgeons needed to main-
tain surgical services across 12 scenarios. These scenarios were
based on three different sizes of surgical service (small, total 20
surgeons on staff; medium, total 35 surgeons; large, total 50 sur-
geons), and on maintaining four different levels of regular elec-
tive surgical volume during the COVID-19 outbreak (0, 25, 50 or
75 per cent of regular elective surgical volume continued).
Minimum surgical services included emergency surgery duties
the surgeons would normally undertake, as well as the ongoing
elective surgical activities within the different scenarios pre-
sented. The questions answered by the expert surgeons for this
elicitation exercise are available in Appendix S2.
Development of framework
The estimates of COVID-19 absence rates from the cross-
sectional study were benchmarked against the minimum staffing
requirements from the expert elicitation exercise, to develop a
framework for predicting the availability of staff for elective sur-
gery capacity throughout COVID-19 outbreaks (Fig. 1). The frame-
work was stratified by surgical service size, level of regular
elective surgical volume during the COVID-19 outbreak, and time
since local COVID-19 emergence. The framework included the
following components.
COVID-19-related absence
Reported mean average rates of COVID-19-related absence were
mapped on to the three surgical team sizes to estimate the num-
ber of surgeons away from work because of COVID-19.
Non-COVID-19-related absence
A further 10 per cent of the total number of available surgeons
was subtracted to account for baseline work absence (sick leave
for disease other than COVID-19, annual leave, all other reasons
for absence regardless of the pandemic)19.
Surgeons required by surgical service
The experts were presented with three surgical service sizes (20,
35 or 50 surgeon staff) and a range of ongoing elective activity (0,
25, 50 or 75 per cent) and asked to provide the minimum number
of surgeons required to sustain services in each scenario. The
mean average from the expert elicitation for each scenario was
taken for use in the model.
Surgeons available to work
The number of surgeons within each size of surgical service avail-
able to attend work was calculated by taking the baseline surgical
service size and subtracting the number of surgeons absent ow-
ing to COVID-19 and the number of absent for non-COVID-19-
related reasons.
Surgeons available for redeployment
The number of surgeons available for redeployment was defined
as number of surgeons available to work but not required to
maintain the surgical service, and therefore available for rede-
ployment to another part of the hospital. This was determined by
subtracting the minimum number of surgeons required to run
the surgical services from the total number of surgeons available
to work.
Sensitivity analysis
A sensitivity analysis of hospitals at CRITCON level 2 or greater
was performed to understand the behaviour of the prediction
model in hospitals where critical care capacity is reduced (un-
precedented levels, full stretch or last resource).
Statistical analysis
Differences in COVID-19-related absence rates between different
COVID-19 hospital status groups and across CRITCON levels
were assessed using linear regression models, with two-sided
P < 0.050 considered statistically significant. Analyses were con-




There were a total of 451 data inputs (Fig. S1). Data were captured
across 364 hospitals and 65 countries (Table S3). A total of 13 sur-
gical specialties contributed to the study: colorectal surgery,
acute-care surgery, upper gastrointestinal and hepatobiliary, or-
thopaedics, paediatric surgery, otolaryngology and head and
neck, vascular, obstetrics and gynaecology, urology, plastic sur-
gery, neurosurgery, cardiothoracic, and maxillofacial and oral
surgery. Overall, 61 responses (13.5 per cent) were from hospitals
that had not admitted patients with COVID-19, 329 (72.9 per
cent ) were from hospitals currently treating patients with
COVID-19, and 60 (13.3 per cent) were from hospitals that had
previously treated COVID-19 but did not have patients with
COVID-19 at the time of response. Of 329 hospitals currently
treating patients COVID-19, 236 (71.7) were at CRITCON levels of
unprecedented critical care demand or worse (levels 2–4).
Over the first 6 weeks of outbreaks, the fortnightly averaged
COVID-19-related absence rates ranged from 20.5 to 24.7 per cent
(Fig. 2). This decreased to 9.2–13.8 per cent during weeks 7–12.
Both surgeon absence owing to sickness and other COVID-19-
related reasons followed a similar trend (Table S4). Absence rates
among senior surgeons were mildly higher than those in junior
surgeons but followed the same upward trend in the first 6
weeks, with a decrease thereafter (Table S5). COVID-19-related ab-
sence rates were broadly consistent across countries when strati-
fied by time since local COVID-19 emergence (Table S6).
No significant difference was found in absence rates between
hospitals currently treating COVID-19 and those not currently
treating patients with COVID-19. Among hospitals currently
treating COVID-19, there was no statistically significant differ-
ence in COVID-19-related absence rates between CRITCON levels
(P¼ 0.814) (Table S7). The COVID-19-related absence rate was 18.0
(95 per cent c.i. 14.7 to 21.3) per cent in hospitals at CRITCON
level 0, 21.0 (18.4 to 23.6) per cent at level 1, 23.7 (22.2 to 25.2) per
cent at level 2, 19.9 (18.3 to 21.4) per cent at level 3, and 20.6 (17.1
to 24.1) per cent at level 4 (Fig. 3).
Expert elicitation exercise
Of surgeons invited to participate in the expert elicitation exer-
cise, all 22 responded. Experts represented 12 countries (Table S3)
and eight surgical specialties (colorectal surgery, acute-care sur-
gery, paediatric surgery, upper gastrointestinal/hepatic surgery,
orthopaedics, cardiothoracic, maxillofacial and oral surgery, and
general surgery). Depending on the elective surgical volume, the
minimum number of surgeons required was determined as 6–12
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in small surgical services, 9–20 in medium surgical services, and
12–26 in large surgical services.
Development of prediction framework
Considering real-world absence rates, across small, medium, and
large surgical services there would be sufficient staffing available
to maintain at least 75 per cent of regular elective surgical vol-
ume at all points throughout future COVID-19 outbreaks. In addi-
tion, there would potentially be surgeons available for
redeployment across most of the scenarios (Table 1). A sensitivity
analysis was performed for hospitals at CRITCON level 2 or
greater, with similar findings in terms of surgeon absence and
availability (Table S8).
Discussion
This study presents a framework for prediction of elective surgi-
cal capacity during COVID-19 outbreaks. It demonstrates that,
taking into account COVID-19-related absences, sufficient work-
force capacity within surgical services remains to deliver at least
75 per cent of regular elective surgical volume during COVID-19
outbreaks. There is also scope for redeployment of surgeons to
contribute to the wider hospital response.
Time since start of COVID-19


















Fig. 2 Proportion of surgical doctors absent from work during pandemic by time since local COVID-19 emergence









































Fig. 3 Proportion of surgical doctors absent from work during pandemic according to COVID-19 status in hospital and CRITCON levels
*Hospital that had not yet admitted patients with COVID-19. †Hospital that had previously treated patients with COVID-19, but was not currently doing so.
‡Hospital currently treating patients with COVID-19. The CRITCON scoring system is designed to report hospital capacity under conditions of systemic stress: level
0, business as usual; level 1, normal winter; level 2, unprecedented; level 3, full stretch; level 4, emergency. The CRITCON level was collected in hospitals that
currently had patients with COVID-19 to define the severity of system stress on hospital capacity.
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An estimated 28.4 million elective operations have been can-
celled owing to COVID-191, including 5.3 million in Europe and
Central Asia, and 4.5 million in North America. Although this
was an appropriate response during the initial COVID-19 impact,
it is not a sustainable approach during future outbreaks. To pre-
vent a deterioration in population health, safe elective surgery
must continue during future COVID-19 outbreaks. The frame-
work presented can be used for surgical teams to plan their elec-
tive activities, using their own team size and the available
human resources. Infrastructure availability (such as operating
theatre and ward space) and patient-level risk also need to be
considered when deciding the volume of elective surgery to be
maintained in upcoming surges.
Surgeons’ absence rates varied as the outbreak progressed,
following a similar pattern to the expected number of cases in
communities throughout an outbreak21. However, absence rates
did not correlate with the level of strain on hospital resources
and bed capacity, as measured by CRITCON. A variety of factors
can influence staff infection rates at particular time points, such
as testing policies or staff protection strategies. Additionally, the
CRITCON grading system was created for UK hospitals and might
be difficult to apply to a broad range of countries. Hospitals that
were no longer admitting patients with COVID-19 still experi-
enced surgeon absence, suggesting that SARS-CoV-2 transmis-
sion in the community might be one of the main drivers of
surgeons’ sickness.
Furthermore, during the majority of the outbreak (first 10
weeks), the proportion of surgeons absent owing to isolation,
shielding, and family care was higher than the proportion sick
with COVID-19 (Table S4). Future recommendations regarding
staff selection for testing and the ideal length of isolation could
influence work absence22. Emerging evidence of antibody testing
may allow more surgeons to be available safely, but further evi-
dence is needed regarding reinfection rates23.
This study had limitations. First, sickness and absence rates
might have been affected by factors not assessed in this study.
Specific measures to mitigate SARS-CoV-2 spread were not
reported, and could have influenced absence rates, both for sick-
ness prevalence (such as social distancing measures), isolation
rates (testing availability) and family care (national or local lock-
down forcing active adults to take care of dependents). Team
management strategies already in place were not collected, and
might have influenced absence rates, such as rota adaptations,
workforce redistributions, and ‘hot’ and ‘cold’ units. Second, the
minimum number of surgeons needed might have been influ-
enced by experts’ backgrounds, such as specialty, whether they
work in a high- or low-income country, and whether they work in
a central versus district hospital. The way that emergency volume
was factored in was not fixed, and this might have been underes-
timated by surgeons working in teams where elective procedures
make up the majority of the work (for example in cancer centres)
and overestimated in hospitals where emergency surgery is the
predominant activity (such as trauma centres).
The framework developed in this study is a starting point for
surgical team management during future outbreaks. Decisions
regarding maintaining elective surgery should take into consider-
ation the available surgical staff but also hospital resource use,
particularly theatre space and critical care capacity. Different
surgical specialties might be able to cope differently with surgeon
absence; for example, an ophthalmology service may be able to
accommodate more absenteeism without effecting surgical vol-
ume than a hepatobiliary surgery service. In addition, selection of








Staff at work based on baseline team size, accounting for absence rates
0–2 weeks 2–4 weeks 4–6 weeks 6–8 weeks 8–10 weeks 10–12 weeks
Small
(n ¼ 20)
25 12 Staff at work 14 13 13 15 15 16
Available for redeployment* 2 1 1 3 3 4
50 10 Staff at work 14 13 13 15 15 16
Available for redeployment* 4 3 3 5 5 6
75 8 Staff at work 14 13 13 15 15 16
Available for redeployment* 6 5 5 7 7 8
100 6 Staff at work 14 13 13 15 15 16
Available for redeployment* 8 7 7 9 9 10
Medium
(n ¼ 35)
25 20 Staff at work 24 23 23 27 27 28
Available for redeployment* 4 3 3 7 7 8
50 16 Staff at work 24 23 23 27 27 28
Available for redeployment* 9 7 8 11 11 13
75 13 Staff at work 24 23 23 27 27 28
Available for redeployment* 12 10 11 14 14 16
100 9 Staff at work 24 23 23 27 27 28
Available for redeployment* 15 13 14 17 17 19
Large
(n ¼ 50)
25 26 Staff at work 35 33 33 38 38 40
Available for redeployment* 9 7 7 12 13 15
50 21 Staff at work 35 33 33 38 38 40
Available for redeployment* 14 12 12 17 18 20
75 16 Staff at work 35 33 33 38 38 40
Available for redeployment* 19 17 17 22 22 24
100 12 Staff at work 35 33 33 38 38 40
Available for redeployment* 23 21 21 26 26 28
The expert consultant group was asked to provide the minimum number of surgeons needed for different sized teams (small, 20; medium, 35; large, 50) when there
was a 25, 50, 75 or 100 per cent elective surgery cancellation rate. The minimum number of surgeons was applied to the team sizes reported by respondents and
was rounded up to prevent underestimation. *Number of surgeons available for redeployment from each team ¼ baseline team – (surgeons absent owing to COVID-
19þ surgeons absent for other reasons (vacation, childcare, and all other reasons factored as 10 per cent)) – minimum number of surgeons needed per team.
Surgeon absence for other reasons included not only COVID-19-related reasons such as shielding, self-isolation or care for sick dependents, but also baseline
absence rates reported by Gianino et al.19. The 10 per cent baseline absence rates include other vacation leave, childcare, and sick leave for reasons other than
COVID. This is compliant with the 1.4 per cent sickness leave rates reported by the National Health Service for February 202020.
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staff for redeployment to support other departments should take
into consideration the different roles of junior and senior doctors
within surgical teams.
This prediction model is a guide, and its application should be
tailored according to local resources and service needs. These
may vary based on staff demographics (older surgeons are more
likely to self-isolate), emergency surgery workload, and surgical
specialty.
Funding
National Institute for Health Research (NIHR) Global Health
Research Unit, NIHR 16.136.79
Association of Coloproctology of Great Britain and Ireland
Bowel and Cancer Research
Bowel Disease Research Foundation
Association of Upper Gastrointestinal Surgeons
British Association of Surgical Oncology
British Gynaecological Cancer Society
European Society of Coloproctology
NIHR Academy
Sarcoma UK
Vascular Society for Great Britain and Ireland
Yorkshire Cancer Research
Acknowledgements
This report was funded by a National Institute for Health
Research (NIHR) Global Health Research Unit Grant (NIHR
16.136.79) using UK aid from the UK Government to support global
health research; the Association of Coloproctology of Great Britain
and Ireland, Bowel and Cancer Research, Bowel Disease Research
Foundation; Association of Upper Gastrointestinal Surgeons;
British Association of Surgical Oncology; British Gynaecological
Cancer Society; European Society of Coloproctology; NIHR
Academy; Sarcoma UK; Vascular Society for Great Britain and
Ireland; and Yorkshire Cancer Research. The funders had no role
in the study design, data collection, analysis and interpretation, or
writing of this report. The views expressed are those of the
authors and not necessarily those of the National Health Service,
the NIHR, or the UK Department of Health and Social Care.
Disclosure. The authors declare no conflict of interest.
Supplementary material
Supplementary material is available at BJS Open online.
References
1. COVIDSurg Collaborative. Elective surgery cancellations due to
the COVID-19 pandemic: global predictive modelling to inform
surgical recovery plans. Br J Surg 2020; DOI:10.1002/bjs.11746
[Epub ahead of print]
2. COVIDSurg Collaborative. Mortality and pulmonary complications
in patients undergoing surgery with perioperative SARS-CoV-2 in-
fection: an international cohort study. Lancet 2020;396:27–38
3. Lei S, Jiang F, Su W, Chen C, Chen J, Mei W et al. Clinical charac-
teristics and outcomes of patients undergoing surgeries during
the incubation period of COVID-19 infection. EClinicalMedicine
2020;21:100331
4. COVIDSurg Collaborative. Global guidance for surgical care dur-
ing the COVID-19 pandemic. Br J Surg 2020;107:1097–1103
5. De Simone B, Chouillard E, Di Saverio S, Pagani L, Sartelli M, Biffl
W et al. Emergency surgery during the COVID-19 pandemic:
what you need to know for practice. Ann R Coll Surg Engl
2020,102:323–332
6. Soreide K, Hallet J, Matthews JB, Schnitzbauer AA, Line PD, Lai
PBS et al. Immediate and long-term impact of the COVID-19 pan-
demic on delivery of surgical services. Br J Surg 2020; DOI:
10.1002/bjs.11670 [Epub ahead of print]
7. Willan J, King AJ, Jeffery K, Bienz N. Challenges for NHS hospi-
tals during covid-19 epidemic. BMJ 2020;368:m1117
8. Mowbray N, Ansell J, Horwood J, Cornish J, Rizkallah P, Parker A
et al. Safe management of surgical smoke in the age of COVID-
19. Br J Surg 2020;107:1406–1413
9. Coccolini F, Tartaglia D, Puglisi A, Lodato M, Chiarugi M. SARS-
CoV-2 is present in peritoneal fluid in COVID-19 patients. Ann
Surg 2020;272:e240
10. Gupta S, Parker J, Smits S, Underwood J, Dolwani S. Persistent vi-
ral shedding of SARS-CoV-2 in faeces—a rapid review. Colorectal
Dis 2020;22:611–620
11. Guo X, Wang J, Hu D, Wu L, Gu L, Wang Y et al. Survey of COVID-
19 disease among orthopaedic surgeons in Wuhan, People’s
Republic of China. J Bone Joint Surg Am 2020;102:847–854
12. Abdelrahman T, Beamish A, Brown C, Egan R, Evans T, Ryan
Harper E et al. Surgery during the COVID-19 pandemic: operating
room suggestions from an international Delphi process. Br J Surg
2020;107:1450–1458
13. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical charac-
teristics of 138 hospitalized patients with 2019 novel
coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;
323:1061–1069
14. Wu Z, McGoogan JM. Characteristics of and important lessons
from the coronavirus disease 2019 (COVID-19) outbreak in
China: summary of a report of 72 314 cases from the Chinese
Center for Disease Control and Prevention. JAMA 2020;323:
1239–1242
15. Adams JG, Walls RM. Supporting the health care workforce dur-
ing the COVID-19 global epidemic. JAMA 2020;323:1439–1440
16. Buerhaus PI, Auerbach DI, Staiger DO. Older clinicians and the
surge in novel coronavirus disease 2019 (COVID-19). JAMA 2020;
323:1777–1778
17. Leung K, Wu JT, Liu D, Leung GM. First-wave COVID-19 trans-
missibility and severity in China outside Hubei after control
measures, and second-wave scenario planning: a modelling im-
pact assessment. Lancet 2020;395:1382–1393
18. NHS England. CRITCON Levels: NHS England (London) Pressure
Surge Guidance. https://www.londonccn.nhs.uk/managing-the-
unit/capacity-escalation/critcon/ (accessed 11 May 2020)
19. Gianino MM, Politano G, Scarmozzino A, Charrier L, Testa M,
Giacomelli S et al. Estimation of sickness absenteeism among
Italian healthcare workers during seasonal influenza epidemics.
PLoS One 2017;12:e0182510
20. NHS Digital. NHS Sickness Absence Rates February 2020, Provisional
Statistics. https://digital.nhs.uk/data-and-information/publica
tions/statistical/nhs-sickness-absence-rates/february-2020-pro
visional-statistics (accessed 11 May 2020)
21. WHO. WHO Coronavirus Disease (COVID-19) Dashboard. https://
covid19.who.int (accessed 27 May 2020)
22. Petherick A. Developing antibody tests for SARS-CoV-2. Lancet
2020;395:1101–1102
23. Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S et al. Development and
clinical application of a rapid IgM-IgG combined antibody test
for SARS-CoV-2 infection diagnosis. J Med Virol 2020;92:
1518-1524
6 | BJS Open, 2020, Vol. 5, No. 1
